28th - 29th January 2021 (GMT+01:00) Europe/London
This event is going virtual!
After the success of the last three Artificial intelligence events in 2018, 2019 and 2020, we are back again in 2021. This time it will be even bigger and better with a new format- VIRTUAL!
This year’s virtual event will be held across two-days with afternoon sessions appealing to our multidisciplinary audience.
We invite all radiologists (consultants and trainees), radiographers, physicists, oncologists as well as other healthcare professionals and those with an interest in AI to join us at this exciting event.
Meet our sponsors!
Exhibit at AI 2021
The 'Artificial intelligence in practice 2021' event offers sponsors and exhibitors an excellent opportunity to reach out to a large number of multidisciplinary medical professionals in a relaxed environment along with an opportunity to speak at this event. To find out more information please email firstname.lastname@example.org.
Registration Fees (Include both days of the virtual event)
Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit: https://www.adacap.com/.
Aidence was founded in Amsterdam in November 2015 by Mark-Jan Harte (CEO) and Jeroen van Duffelen (COO). It rallies the brightest data scientists, medical and regulatory professionals, and software engineers to create AI applications that support the oncology pathway and contribute to better, more affordable healthcare. The purpose-driven team is building AI solutions that seamlessly integrate into the clinical workflow, ensuring speed, accuracy, and ease of use. Aidence’s first medical solution is Veye Chest, an AI-based assistant for lung nodules on chest CT. Veye Chest has been trained on over 45,000 chest CT scans and is independently validated by radiologists at the University of Edinburgh. Veye Chest is CE-marked as a class IIa medical device and currently running in routine practice and lung cancer screening programmes across the UK and Europe. Veye Reporting has recently been added to Veye Chest as an interactive module that delivers a customizable report prepopulated with results from Veye Chest. In 2020, Aidence received the AI in Health and Care Award to help the UK's National Health Service (NHS) improve lung cancer prognosis. In March 2020, they set-up the International Consortium for COVID-19 Imaging AI (ICOVAI), to build an AI solution for COVID-19 on chest CTs, a project founded by the Horizon 2020 EU grant.
Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999 www.radiology.bayer.co.uk
GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.
OSL is an independent provider of medical equipment and software to the NHS and private hospitals in the UK, Ireland and worldwide. Watson Elementary® AI based computer aided diagnostic software for mpMRI Prostate. Fast, efficient with huge time savings including auto-voluming and auto-segmentation.
Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. www.philips.co.uk/healthcare
Qure has been building AI solutions for medical imaging since last 4 years which are now present across 20+ countries in 150+ sites. Qure's products are focused at improving quality of care through faster, more accurate diagnostic imaging making it more affordable and accessible through the power of deep learning. The company's product portfolio includes AI solutions for automated chest x-ray (qXR) and head CT (qER) reads deployed across triage, reporting assistance and progression monitoring use cases. Not only are they well adopted, they've also got some landmark publications including eminent journals like The Lancet. If you are a radiologist looking to manage workflows better, try out Qure's AI as your assistant.
Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company, Siemens Healthineers enables healthcare providers worldwide to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalising healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care to patients. Further information is available at www.siemens-healthineers.co.uk
Zebra Medical Vision explores data to optimize clinical decisions within the current workflow by providing actionable insights to identify treatment gaps and coordinate care. Zebra Medical Vision provides access to an ever-growing number of FDA cleared AI solutions, integrated into radiologist workflow at an affordable, fixed annual fee. Zebra-Med’s Platform allows healthcare institutions such as Intermountain Health, Oxford University Hospital, Spectrum Health, Northwell Health and Apollo hospitals to identify patients at risk of disease and initiate preventative treatment pathways to improve patient care. The company’s AI solutions analyze millions of clinical images in real time, detecting various medical indications, and alerting the relevant stakeholders in the hospital or clinic. Our AI solution offering ranges from Oncology and Bone Health to the world’s first Multi-modality Triage AI solutions for Mammograms, CTs and X-rays, that alerts at point of care.